Close Menu

NEW YORK (GenomeWeb) – Highmark Health announced today that it has agreed to evaluate the utility of YouScript's Precision Prescribing Software, which is designed for safer, more targeted prescribing of medications for patients taking multiple drugs.

The evaluation will be conducted through Highmark's VITAL Innovation Program, a test-and-learn platform that facilitates real-world testing of early-stage medical innovations to produce evidence related to patient experience, and clinical and financial outcomes, Highmark said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.